001     276089
005     20250121165738.0
024 7 _ |a 10.1007/s11910-024-01400-8
|2 doi
024 7 _ |a pmid:39820740
|2 pmid
024 7 _ |a 1528-4042
|2 ISSN
024 7 _ |a 1534-6293
|2 ISSN
037 _ _ |a DZNE-2025-00170
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Pellerin, David
|b 0
245 _ _ |a Recent Advances in the Genetics of Ataxias: An Update on Novel Autosomal Dominant Repeat Expansions.
260 _ _ |a Philadelphia, Pa.
|c 2025
|b Current Science Inc.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1737452494_5211
|2 PUB:(DE-HGF)
|x Review Article
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Autosomal dominant cerebellar ataxias, also known as spinocerebellar ataxias (SCAs), are genetically and clinically diverse neurodegenerative disorders characterized by progressive cerebellar dysfunction. Despite advances in sequencing technologies, a large proportion of patients with SCA still lack a definitive genetic diagnosis. The advent of advanced bioinformatic tools and emerging genomics technologies, such as long-read sequencing, offers an unparalleled opportunity to close the diagnostic gap for hereditary ataxias. This article reviews the recently identified repeat expansion SCAs and describes their molecular basis, epidemiology, and clinical features.Leveraging advanced bioinformatic tools and long-read sequencing, recent studies have identified novel pathogenic short tandem repeat expansions in FGF14, ZFHX3, and THAP11, associated with SCA27B, SCA4, and SCA51, respectively. SCA27B, caused by an intronic (GAA)•(TTC) repeat expansion, has emerged as one of the most common forms of adult-onset hereditary ataxias, especially in European populations. The coding GGC repeat expansion in ZFHX3 causing SCA4 was identified more than 25 years after the disorder's initial clinical description and appears to be a rare cause of ataxia outside northern Europe. SCA51, caused by a coding CAG repeat expansion, is overall rare and has been described in a small number of patients. The recent identification of three novel pathogenic repeat expansions underscores the importance of this class of genomic variation in the pathogenesis of SCAs. Progress in sequencing technologies holds promise for closing the diagnostic gap in SCAs and guiding the development of therapeutic strategies for ataxia.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Autosomal dominant cerebellar ataxia
|2 Other
650 _ 7 |a FGF14
|2 Other
650 _ 7 |a Genome sequencing
|2 Other
650 _ 7 |a Spinocerebellar ataxia
|2 Other
650 _ 7 |a Spinocerebellar ataxia 27B (SCA27B)
|2 Other
650 _ 7 |a Spinocerebellar ataxia 4 (SCA4)
|2 Other
650 _ 7 |a Spinocerebellar ataxia 51 (SCA51)
|2 Other
650 _ 7 |a THAP11
|2 Other
650 _ 7 |a ZFHX3
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Spinocerebellar Ataxias: genetics
|2 MeSH
650 _ 2 |a Spinocerebellar Ataxias: diagnosis
|2 MeSH
650 _ 2 |a DNA Repeat Expansion: genetics
|2 MeSH
700 1 _ |a Iruzubieta, Pablo
|b 1
700 1 _ |a Xu, Isaac R L
|b 2
700 1 _ |a Danzi, Matt C
|b 3
700 1 _ |a Cortese, Andrea
|b 4
700 1 _ |a Synofzik, Matthis
|0 P:(DE-2719)2811275
|b 5
|u dzne
700 1 _ |a Houlden, Henry
|b 6
700 1 _ |a Zuchner, Stephan
|b 7
700 1 _ |a Brais, Bernard
|b 8
773 _ _ |a 10.1007/s11910-024-01400-8
|g Vol. 25, no. 1, p. 16
|0 PERI:(DE-600)2094171-7
|n 1
|p 16
|t Current neurology and neuroscience reports
|v 25
|y 2025
|x 1528-4042
856 4 _ |u https://pub.dzne.de/record/276089/files/DZNE-2025-00170_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/276089/files/DZNE-2025-00170_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |o oai:pub.dzne.de:276089
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2811275
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2025-01-07
|w ger
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2025-01-07
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CURR NEUROL NEUROSCI : 2022
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-07
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-07
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-07
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CURR NEUROL NEUROSCI : 2022
|d 2025-01-07
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21